Clovis Oncology UK Limited
11
J Kate Stickles
12/11/2022
01/26/2023
Yes
v
| SealedDoc(s), JNTADMN, CLMSAGNT |
Assigned to: Bankruptcy Judge J Kate Stickles Chapter 11 Voluntary Asset |
|
Debtor Clovis Oncology UK Limited
2nd Floor 77 Farringdon Road London OUTSIDE U. S. United Kingdom Tax ID / EIN: 00-0000000 |
represented by |
Robert J. Dehney
Morris, Nichols, Arsht & Tunnell 1201 N. Market Street P O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 Fax : (302) 658-3989 Email: rdehney@mnat.com Matthew O Talmo
Morris, Nichols Arsht & Tunnell LLP 1201 N. Market Street P.O. Box 1347 Wilmington, DE 19899-1347 302-658-9200 Fax : 302-658-3989 Email: mtalmo@mnat.com |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
| |
Claims Agent Kroll Restructuring Administration LLC
(f/k/a Prime Clerk LLC) 55 East 52nd Street 17th Floor New York, NY 10055 212-257-5450 |
| Date Filed | # | Docket Text |
|---|---|---|
| 01/26/2023 | 13 | Schedules/Statements filed: , Stmt of Financial Affairs,. Filed by Clovis Oncology UK Limited. (Talmo, Matthew) (Entered: 01/26/2023) |
| 01/26/2023 | 12 | Schedules/Statements filed: Sch A-B, Sch D, Sch E-F, Sch G, Sch H, , Sum of Assets and Liabilities, Decl Concerning Debtors Schs,. Filed by Clovis Oncology UK Limited. (Talmo, Matthew) (Entered: 01/26/2023) |
| 01/26/2023 | 11 | [SEALED] Schedules/Statements filed: , Stmt of Financial Affairs,. Filed by Clovis Oncology UK Limited. (Talmo, Matthew) (Entered: 01/26/2023) |
| 01/26/2023 | 10 | [SEALED] Schedules/Statements filed: Sch A-B, Sch D, Sch E-F, Sch G, Sch H, , Sum of Assets and Liabilities, Decl Concerning Debtors Schs,. Filed by Clovis Oncology UK Limited. (Talmo, Matthew) (Entered: 01/26/2023) |
| 12/15/2022 | 9 | An order has been entered in this case in accordance with Bankruptcy Rule 1015(b) directing the procedural consolidation and joint administration of the chapter 11 cases of Clovis Oncology, Inc., Clovis Oncology UK Limited, and Clovis Oncology Ireland Limited. The docket in the chapter 11 case of Clovis Oncology, Inc., Case No. 22-11292 (JKS), should be consulted for all matters affecting these cases. (related document(s)8) (SJM) (Entered: 12/15/2022) |
| 12/14/2022 | 8 | Order Directing Joint Administration of Cases " An order has been entered in this case in accordance with Bankruptcy Rule 1015(b) directing the procedural consolidation and joint administration of the chapter 11 cases of Clovis Oncology, Inc., Clovis Oncology UK Limited, and Clovis Oncology Ireland Limited. The docket in the chapter 11 case of Clovis Oncology, Inc., Case No. 22-11292 (JKS), should be consulted for all matters affecting these cases." Signed on 12/14/2022 (AJL) (Entered: 12/14/2022) |
| 12/12/2022 | 7 | Order Approving Motion for Admission pro hac vice (Related Doc # 5) (related document(s)5) Order Signed on 12/12/2022. (AJL) (Entered: 12/12/2022) |
| 12/12/2022 | 6 | Certificate of Service Certificate of Service to Entry of Appearance and Request for Notices of 3B Pharmaceuticals GmbH Pursuant to Fed. R. Bankr. P. 2002 and 9010 and Del. Bankr. L.R. 2002-1(d) Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022) |
| 12/12/2022 | Attorney Paul D. Moak and Mark W. Eckard for 3B Pharmaceuticals GmbH added to case Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022) | |
| 12/12/2022 | 5 | Motion to Appear pro hac vice of Paul D. Moak. Receipt Number 3908008, Filed by 3B Pharmaceuticals GmbH. (Eckard, Mark) (Entered: 12/12/2022) |